Comprehensive Blood & Cancer Center

Make An Appointment | News & Events | Contact

Skip to content

Saturday18 May 2013

Skip to content

Drug Dictionary

Display #

Title
Obesity Linked with Worse Survival in Hormone Receptor-Positive Breast Cancer
Rituxan Maintenance Shows Benefit in Follicular Lymphoma
Aromatase Inhibitors May Increase Risk of Heart Disease
Xgeva Delays Bone Complications in Women with Metastatic Breast Cancer
Higher Copayments May Limit Use of Breast Cancer Therapy
Oncotype DX Influences Breast Cancer Treatment Decisions
Estrogen Alone May Reduce Breast Cancer Risk in Certain Women
Circulating Tumor Cells Linked with Recurrence of Early Breast Cancer
Zometa Fails to Reduce Recurrence of Early Breast Cancer
Active Surveillance Linked with Better Quality of Life in Prostate Cancer
Continuous Revlimid May Improve Outcomes in Newly Diagnosed Multiple Myeloma
Xgeva Delays Spread of Prostate Cancer to Bone
Revlimid Maintenance Slows Myeloma Progression After Stem Cell Transplant
Improved Survival with Zometa in Multiple Myeloma
Nplate Active for More than Five Years in Adults with Chronic ITP
Tasigna Improves Outcomes in Newly Diagnosed CML
Committee Votes Against Use of Drugs for Prostate Cancer Risk Reduction
Rituxan Delays Need for Chemotherapy in Follicular Lymphoma
Investigational Vaccine Promising in Glioblastoma
Women with Personal History of Breast Cancer May Benefit from MRI
Repeated Diagnostic Imaging Tests Frequent Among Heart Patients
Effexor Preferred over Neurontin for Hot Flashes Among Breast Cancer Survivors
Halaven Approved for the Treatment of Late-Stage Breast Cancer

Top